Evidence map›Paper›PMID 31121840›Full record

ReviewJournal of clinical medicine2019

Quantifying Cancer Epithelial-Mesenchymal Plasticity and its Association with Stemness and Immune Response.

Dongya Jia, Xuefei Li, Federico Bocci, Shubham Tripathi, Youyuan Deng, Mohit Kumar Jolly, José N Onuchic, Herbert Levine

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 83 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Frontiers in cell and developmental biology · 2024
    Review
  18. Cancer spreading patterns based on epithelial-mesenchymal plasticity.Frontiers in cell and developmental biology · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Dongya JiaCenter for Theoretical Biological Physics, Rice University, Houston, TX 77005, USA. dj9@rice.edu.ORCID 0000-0002-6307-8580
Xuefei LiCenter for Theoretical Biological Physics, Rice University, Houston, TX 77005, USA. Xuefei.Li@rice.edu.
Federico BocciCenter for Theoretical Biological Physics, Rice University, Houston, TX 77005, USA. fb20@rice.edu.ORCID 0000-0003-4302-9906
Shubham TripathiPhD Program in Systems, Synthetic, and Physical Biology, Rice University, Houston, TX 77005, USA. shubtri@rice.edu.
Youyuan DengCenter for Theoretical Biological Physics, Rice University, Houston, TX 77005, USA. Youyuan.Deng@rice.edu.
Mohit Kumar JollyCentre for BioSystems Science and Engineering, Indian Institute of Science, Bangalore 560012, India. mkjolly@iisc.ac.in.
José N OnuchicCenter for Theoretical Biological Physics, Rice University, Houston, TX 77005, USA. jonuchic@rice.edu.
Herbert LevineCenter for Theoretical Biological Physics, Rice University, Houston, TX 77005, USA. h.levine@northeastern.edu.
Center for Theoretical Biological Physics · USIndian Institute of Science Bangalore · INNortheastern University · USRice University · US

Funding

John S. Dunn Foundation Collaborative Research Award N/AMarjory Meyer Hasselmann Fellowship for academic excellence in chemistry N/ANational Science Foundation CHE-1614101National Science Foundation PHY-1427654National Science Foundation PHY-1605817Ramanujan Fellowship awarded by SERB, DST, Government of India SB/S2/RJN-049/2018
6 · The paper itself

Abstract

Cancer cells can acquire a spectrum of stable hybrid epithelial/mesenchymal (E/M) states during epithelial-mesenchymal transition (EMT). Cells in these hybrid E/M phenotypes often combine epithelial and mesenchymal features and tend to migrate collectively commonly as small clusters. Such collectively migrating cancer cells play a pivotal role in seeding metastases and their presence in cancer patients indicates an adverse prognostic factor. Moreover, cancer cells in hybrid E/M phenotypes tend to be more associated with stemness which endows them with tumor-initiation ability and therapy resistance. Most recently, cells undergoing EMT have been shown to promote immune suppression for better survival. A systematic understanding of the emergence of hybrid E/M phenotypes and the connection of EMT with stemness and immune suppression would contribute to more effective therapeutic strategies. In this review, we first discuss recent efforts combining theoretical and experimental approaches to elucidate mechanisms underlying EMT multi-stability (i.e., the existence of multiple stable phenotypes during EMT) and the properties of hybrid E/M phenotypes. Following we discuss non-cell-autonomous regulation of EMT by cell cooperation and extracellular matrix. Afterwards, we discuss various metrics that can be used to quantify EMT spectrum. We further describe possible mechanisms underlying the formation of clusters of circulating tumor cells. Last but not least, we summarize recent systems biology analysis of the role of EMT in the acquisition of stemness and immune suppression.

Indexed as

CTC clustersEMT metricsEMT spectrumepithelial–mesenchymal transitionhybrid epithelial/mesenchymal phenotypesimmune suppressionstemnesssystems biology

Identifiers

PMID31121840
PMCPMC6572429
OpenAlexW2936108085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.